基于瘤遗传和分子特征的周围胆管癌的个性化治疗
He-Nan Tang1, Ming-Wei Wang2, Xue-Song Liu3
1Department of Outpatient, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
World journal of gastrointestinal surgery
|October 1, 2024
概括
围状胆瘤 (pCCA) 的遗传概况揭示了像酸激酶M2这样的关键分子驱动因素. 了解这些特征可以实现个性化的治疗策略,以获得更好的结果.
科学领域:
- 胃肠道手术 胃肠道手术
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 周围胆管癌 (pCCA) 是一种具有挑战性的恶性瘤.
- 基因和分子分析对于理解pCCA至关重要.
- 之前的研究已经确定了几个关键的异常驱动pCCA的增长.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K